Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Olfactory dysfunction in patients with neuromyelitis optica.
Interferon alpha association with neuromyelitis optica.
Inhibition of Myelin-Cleaving Poteolytic Activities by Interferon-Beta in Rat Astrocyte Cultures. Comparative Analysis between Gelatinases and Calpain-II.
Targeting estrogen receptor β in microglia and T cells to treat experimental autoimmune encephalomyelitis.
Supine and upright urodynamic evaluation of incontinent ileovesicostomy in wheelchair-bound adults with neurogenic bladder.
Interferon Beta and Long-term Disability in Multiple Sclerosis-Reply.
Nitric oxide plays a dual role in the oxidative injury of cultured rat microglia but not astroglia.
Ipilimumab in patients with melanoma and autoimmune disease.
[Multiple sclerosis: socioeconomic effects and impact on quality of life].
Serum proteomics in multiple sclerosis disease progression.
Internal tremor in Parkinson's disease, multiple sclerosis, and essential tremor.
Motor cortex rTMS improves dexterity in relapsing-remitting and secondary progressive multiple sclerosis.
Relationship between gait initiation and disability in individuals affected by multiple sclerosis.
Cognitive and psychiatric comorbidities in neuromyelitis optica.
Spasticity in multiple sclerosis: Associations with impairments and overall quality of life.
Assessment of a program to encourage the multidisciplinary management of urinary disorders in multiple sclerosis.
Serum-free spheroid suspension culture maintains mesenchymal stem cell proliferation and differentiation potential.
Pain and Cognition in Multiple Sclerosis.
Fatigue at time of CIS is an independent predictor of a subsequent diagnosis of multiple sclerosis.
The current role of mitoxantrone in the treatment of multiple sclerosis.
Deep grey matter involvement in multiple sclerosis: key player or bystander?
The potential of epigenetic therapies in neurodegenerative diseases.
What is the Real Fate of Vitamin D in Multiple Sclerosis?
Subretinal angiostrongyliasis-induced optic neuritis.
Constructing an adaptive care model for the management of disease-related symptoms throughout the course of multiple sclerosis--performance improvement CME.
Pages
« first
‹ previous
…
583
584
585
586
587
588
589
590
591
…
next ›
last »